BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21555676)

  • 1. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.
    Davis EM; Appel LJ; Wang X; Greene T; Astor BC; Rahman M; Toto R; Lipkowitz MS; Pogue VA; Wright JT;
    Hypertension; 2011 Jun; 57(6):1061-8. PubMed ID: 21555676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control, drug therapy, and kidney disease.
    Contreras G; Greene T; Agodoa LY; Cheek D; Junco G; Dowie D; Lash J; Lipkowitz M; Miller ER; Ojo A; Sika M; Wilkening B; Toto RD;
    Hypertension; 2005 Jul; 46(1):44-50. PubMed ID: 15897360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed messages on blood pressure goals.
    Chobanian AV
    Hypertension; 2011 Jun; 57(6):1039-40. PubMed ID: 21555679
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
    Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
    JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.
    Wright JT; Agodoa L; Contreras G; Greene T; Douglas JG; Lash J; Randall O; Rogers N; Smith MC; Massry S;
    Arch Intern Med; 2002 Jul; 162(14):1636-43. PubMed ID: 12123409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management.
    Lash JP; Wang X; Greene T; Gadegbeku CA; Hall Y; Jones K; Kusek JW; Sika M; Unruh M;
    Am J Kidney Dis; 2006 Jun; 47(6):956-64. PubMed ID: 16731290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.
    Juraschek SP; Appel LJ; Miller ER; Mukamal KJ; Lipsitz LA
    Hypertension; 2018 Oct; 72(4):986-993. PubMed ID: 30354704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
    Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
    Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?
    Sica DA
    J Clin Hypertens (Greenwich); 2003; 5(2):159-67. PubMed ID: 12671332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
    Toto RD
    Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.
    Sarnak MJ; Greene T; Wang X; Beck G; Kusek JW; Collins AJ; Levey AS
    Ann Intern Med; 2005 Mar; 142(5):342-51. PubMed ID: 15738453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
    Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
    Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.
    Hall WD; Kusek JW; Kirk KA; Appel LJ; Schulman G; Agodoa LY; Glassock R; Grim C; Randall OS; Massry SG
    Am J Kidney Dis; 1997 May; 29(5):720-8. PubMed ID: 9159306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
    J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD.
    Magriço R; Bigotte Vieira M; Viegas Dias C; Leitão L; Neves JS
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):73-80. PubMed ID: 29101186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
    Appel LJ; Wright JT; Greene T; Kusek JW; Lewis JB; Wang X; Lipkowitz MS; Norris KC; Bakris GL; Rahman M; Contreras G; Rostand SG; Kopple JD; Gabbai FB; Schulman GI; Gassman JJ; Charleston J; Agodoa LY;
    Arch Intern Med; 2008 Apr; 168(8):832-9. PubMed ID: 18443258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
    Norris K; Bourgoigne J; Gassman J; Hebert L; Middleton J; Phillips RA; Randall O; Rostand S; Sherer S; Toto RD; Wright JT; Wang X; Greene T; Appel LJ; Lewis J;
    Am J Kidney Dis; 2006 Nov; 48(5):739-51. PubMed ID: 17059993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.